Laddar...

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis

PURPOSE: The purpose of our study is to report our experience with the use of certolizumab pegol in patients with refractory non-infectious uveitis. OBSERVATIONS: We present a case series of three patients with non-infectious uveitis, treated with twice-monthly subcutaneous certolizumab pegol. All o...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Am J Ophthalmol Case Rep
Huvudupphovsmän: Sharon, Yael, Chu, David S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2020
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068621/
https://ncbi.nlm.nih.gov/pubmed/32190782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2020.100633
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!